Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4676
Invesco Dorsey Wright SmallCap Momentum ETF
DWAS
$411M
| $25.5K | ﹤0.01% |
300
| – | – |
2021 Q2
16 quarters
|
|
4677
Verde Clean Fuels
VGAS
$24M
| $25.4K | ﹤0.01% |
7,394
+3,803
| +106% | +$13K |
2023 Q2
8 quarters
|
|
|
IDAT
4678
DELISTED
iShares Future Cloud 5G and Tech ETF
IDAT
| $25.3K | ﹤0.01% |
700
| – | – |
2024 Q4
2 quarters
|
|
|
LSB
4679
DELISTED
LakeShore Biopharma
LSB
| $25.3K | ﹤0.01% |
24,757
| – | – |
2024 Q2
4 quarters
|
|
4680
Acrivon Therapeutics
ACRV
$85.3M
| $24.9K | ﹤0.01% |
20,925
-11,773
| -36% | -$16.2K |
2022 Q4
10 quarters
|
|
4681
First Guaranty Bancshares
FGBI
$137M
| $24.9K | ﹤0.01% |
3,028
+905
| +43% | +$8K |
2024 Q3
3 quarters
|
|
4682
QuickLogic
QUIK
$217M
| $24.7K | ﹤0.01% |
4,006
-10,971
| -73% | -$60.3K |
2024 Q2
4 quarters
|
|
4683
Northern Technologies International Corp
NTIC
$73.1M
| $24.6K | ﹤0.01% |
3,318
-8,592
| -72% | -$65.6K |
2024 Q2
4 quarters
|
|
4684
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$350M
| $24.6K | ﹤0.01% |
700
-300
| -30% | -$10.9K |
2021 Q2
16 quarters
|
|
4685
Takeda Pharmaceutical
TAK
$57.1B
| $24.4K | ﹤0.01% |
1,577
-77
| -5% | -$1.14K |
2018 Q4
26 quarters
|
|
|
ECO
4686
Okeanis Eco Tankers
ECO
$3.41B
| $24.2K | ﹤0.01% |
1,112
-24,804
| -96% | -$561K |
2023 Q4
6 quarters
|
|
|
BCYC
4687
Bicycle Therapeutics
BCYC
$237M
| $24.2K | ﹤0.01% |
3,476
+168
| +5% | +$1.34K |
2023 Q1
9 quarters
|
|
|
LZMH
4688
LZ Technology Holdings
LZMH
$10.8M
| $24.1K | ﹤0.01% |
+73
| New | +$20.2K |
2025 Q2
0 quarters
|
|
4689
Lineage Cell Therapeutics
LCTX
$235M
| $24K | ﹤0.01% |
26,439
-168,606
| -86% | -$100K |
2022 Q3
11 quarters
|
|
4690
Invivyd
IVVD
$242M
| $24K | ﹤0.01% |
33,510
-79,605
| -70% | -$56.5K |
2023 Q4
6 quarters
|
|
4691
Red Robin
RRGB
$150M
| $23.4K | ﹤0.01% |
4,047
+1,201
| +42% | +$4.65K |
2024 Q3
3 quarters
|
|
|
CGC
4692
Canopy Growth
CGC
$370M
| $23.2K | ﹤0.01% |
19,003
+2,500
| +15% | +$3.33K |
2018 Q4
26 quarters
|
|
4693
Magnachip Semiconductor
MX
$134M
| $23K | ﹤0.01% |
5,782
| – | – |
2024 Q3
3 quarters
|
|
4694
Karyopharm Therapeutics
KPTI
$18.2M
| $23K | ﹤0.01% |
5,333
| – | – |
2013 Q4
46 quarters
|
|
4695
Cardlytics
CDLX
$14.9M
| $22.9K | ﹤0.01% |
1,391
-3,952
| -74% | -$68.2K |
2019 Q1
25 quarters
|
|
|
EMBJ
4696
Embraer S.A. ADS
EMBJ
$13.4B
| $22.8K | ﹤0.01% |
+400
| New | +$18.9K |
2025 Q2
0 quarters
|
|
|
MAXN
4697
DELISTED
Maxeon Solar Technologies
MAXN
| $22.2K | ﹤0.01% |
7,253
| – | – |
2023 Q1
9 quarters
|
|
4698
Ryanair
RYAAY
$28.5B
| $22K | ﹤0.01% |
381
-8,139
| -96% | -$414K |
2025 Q1
1 quarter
|
|
4699
Vertical Aerospace
EVTL
$100M
| $21.7K | ﹤0.01% |
3,200
-12,349
| -79% | -$57.9K |
2025 Q1
1 quarter
|
|
4700
Genius Group
GNS
$28.8M
| $21.6K | ﹤0.01% |
+15,914
| New | +$6.31K |
2025 Q2
0 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.